🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Artificial Intelligence in Colonoscopy

RecruitingNAAges 50 Years - 65 YearsAllJagiellonian University
NCT06786793 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Colorectal cancer is the second most common malignancy in the countries of the European Union. Colonoscopy is the primary method for detecting and preventing the development of colorectal cancer is endoscopic examination. This study aims to evaluate the impact of artificial intelligence on the detection rate of polyps and early stages of colorectal cancer.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Consent to participate in the study, * Age between 50 and 65 years, * Scheduled outpatient colonoscopy. Exclusion Criteria: * Previous colonoscopy, * History of colorectal surgery, * Ongoing biological therapy for any indication, * Primary sclerosing cholangitis, * Familial polyposis syndrome, * Chronic diarrhea, * Ulcerative colitis, * Crohn's disease.
💊

What it tests

  • Computer-aided detection (CADe)
📍

Where

2 sites
MEDICINA Medical Center
Krakow, Poland
Brothers Hospitallers Medical Center, Hospital of St John of god in Krakow
Krakow, Poland
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy